ArticleCancer biology & therapy2025

USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability.

Pu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.